Whitehawk Therapeutics Inc (WHWK)

$1.70 0.00 (N/A)
Market Cap 43.96M
Revenue (ttm) 25.98M
Net Income (ttm) -63.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.15%
Debt to Equity Ratio 0.00
Volume 44,600
Avg Vol 153,194
Day's Range N/A - N/A
Shares Out 24.70M
Stochastic %K 7%
Beta 0.68
Analysts Hold
Price Target $2.00

Latest News on WHWK

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 26, 2025, 8:00 AM EDT - 7 days ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:52 AM EDT - 14 days ago

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Mar 18, 2025, 4:00 PM EDT - 15 days ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company